Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation.

Echevarria C, Gray J, Hartley T, Steer J, Miller J, Simpson AJ, Gibson GJ, Bourke SC.

Thorax. 2018 Aug;73(8):713-722. doi: 10.1136/thoraxjnl-2017-211197. Epub 2018 Apr 21.

2.

Evidence-based controls for epidemics using spatio-temporal stochastic models in a Bayesian framework.

Adrakey HK, Streftaris G, Cunniffe NJ, Gottwald TR, Gilligan CA, Gibson GJ.

J R Soc Interface. 2017 Nov;14(136). pii: 20170386. doi: 10.1098/rsif.2017.0386.

3.

A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak.

Lau MSY, Gibson GJ, Adrakey H, McClelland A, Riley S, Zelner J, Streftaris G, Funk S, Metcalf J, Dalziel BD, Grenfell BT.

PLoS Comput Biol. 2017 Oct 30;13(10):e1005798. doi: 10.1371/journal.pcbi.1005798. eCollection 2017 Oct.

4.

Taken to task: what is and is not an appropriate response to an ERS guidelines task force?

Joos G, Bush A, Burghuber OC, Robalo Cordeiro C, Gaga M, Gibson GJ, Gratziou C, Rigau D, Rohde G, Smyth D, Stolz D, Tonia T, Vestbo J, Welte T, Brusselle G, Miravitlles M.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700952. doi: 10.1183/13993003.00952-2017. Print 2017 Jul. No abstract available.

5.

Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial.

Murphy PB, Rehal S, Arbane G, Bourke S, Calverley PMA, Crook AM, Dowson L, Duffy N, Gibson GJ, Hughes PD, Hurst JR, Lewis KE, Mukherjee R, Nickol A, Oscroft N, Patout M, Pepperell J, Smith I, Stradling JR, Wedzicha JA, Polkey MI, Elliott MW, Hart N.

JAMA. 2017 Jun 6;317(21):2177-2186. doi: 10.1001/jama.2017.4451.

6.

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD.

Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, Wijesinghe M, Harrison RN, Steen N, Simpson AJ, Gibson GJ, Bourke SC.

Thorax. 2017 Aug;72(8):686-693. doi: 10.1136/thoraxjnl-2016-209298. Epub 2017 Feb 24.

7.

What rheumatologists need to know about CRISPR/Cas9.

Gibson GJ, Yang M.

Nat Rev Rheumatol. 2017 Apr;13(4):205-216. doi: 10.1038/nrrheum.2017.6. Epub 2017 Feb 9. Review.

PMID:
28202911
8.

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD.

Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, Wijesinghe M, Harrison RN, Steen N, Simpson AJ, Gibson GJ, Bourke SC.

Thorax. 2016 Feb;71(2):133-40. doi: 10.1136/thoraxjnl-2015-207775.

9.

Chondrocyte miRNAs 221 and 483-5p respond to loss of matrix interaction by modulating proliferation and matrix synthesis.

Yang M, Zhang L, Gibson GJ.

Connect Tissue Res. 2015 Jun;56(3):236-43. doi: 10.3109/03008207.2015.1018384. Epub 2015 Mar 6.

PMID:
25738598
10.

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD.

Steer J, Gibson GJ, Bourke SC.

BMJ Open Respir Res. 2015 Jan 15;2(1):e000069. doi: 10.1136/bmjresp-2014-000069. eCollection 2015.

11.

Diagnosis of muscle diseases presenting with early respiratory failure.

Pfeffer G, Povitz M, Gibson GJ, Chinnery PF.

J Neurol. 2015 May;262(5):1101-14. doi: 10.1007/s00415-014-7526-1. Epub 2014 Nov 7. Review.

PMID:
25377282
12.

Bayesian analysis for inference of an emerging epidemic: citrus canker in urban landscapes.

Neri FM, Cook AR, Gibson GJ, Gottwald TR, Gilligan CA.

PLoS Comput Biol. 2014 Apr 24;10(4):e1003587. doi: 10.1371/journal.pcbi.1003587. eCollection 2014 Apr.

13.

Bayesian inference for an emerging arboreal epidemic in the presence of control.

Parry M, Gibson GJ, Parnell S, Gottwald TR, Irey MS, Gast TC, Gilligan CA.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6258-62. doi: 10.1073/pnas.1310997111. Epub 2014 Apr 7.

14.

New model diagnostics for spatio-temporal systems in epidemiology and ecology.

Lau MS, Marion G, Streftaris G, Gibson GJ.

J R Soc Interface. 2014 Feb 12;11(93):20131093. doi: 10.1098/rsif.2013.1093. Print 2014 Apr 6.

15.

Respiratory health and disease in Europe: the new European Lung White Book.

Gibson GJ, Loddenkemper R, Lundbäck B, Sibille Y.

Eur Respir J. 2013 Sep;42(3):559-63. doi: 10.1183/09031936.00105513. No abstract available.

16.

Lung function and plasma fibrinogen concentrations in the Newcastle Thousand Families birth cohort between age 49 and 51 years.

Pearce MS, Hancox RJ, Parker L, Gibson GJ.

Respirology. 2014 Jan;19(1):53-7. doi: 10.1111/resp.12158.

17.

Non-exponential tolerance to infection in epidemic systems--modeling, inference, and assessment.

Streftaris G, Gibson GJ.

Biostatistics. 2012 Sep;13(4):580-93. doi: 10.1093/biostatistics/kxs011. Epub 2012 Apr 20.

PMID:
22522236
18.

The changing landscape of non-invasive ventilation in amyotrophic lateral sclerosis.

Bourke SC, O'Neill CL, Williams TL, Peel ET, Gibson GJ, McDermott CJ, Shaw PJ.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):368-9. doi: 10.1136/jnnp-2012-302253. No abstract available.

PMID:
22399795
19.

Profound bradycardia associated with NIV removal.

Echevarria C, Bourke SC, Gibson GJ.

Respir Med Case Rep. 2012;5:73-5. doi: 10.1016/j.rmedc.2011.07.006. Epub 2011 Nov 4.

20.

[Rebound hypoxemia after oxygen therapy in acute exacerbation of chronic obstructive lung disease].

Kane B, Turkington PM, Howard LS, Davison AG, Gibson GJ, O'Driscoll BR.

Praxis (Bern 1994). 2011 Dec 14;100(25):1549-51. doi: 10.1024/1661-8157/a000761. German. No abstract available.

PMID:
22161882
21.

Applications of percolation theory to fungal spread with synergy.

Ludlam JJ, Gibson GJ, Otten W, Gilligan CA.

J R Soc Interface. 2012 May 7;9(70):949-56. doi: 10.1098/rsif.2011.0506. Epub 2011 Nov 2.

22.

Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD.

Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC.

Thorax. 2012 Feb;67(2):117-21. doi: 10.1136/thoraxjnl-2011-200332. Epub 2011 Sep 6.

PMID:
21896712
23.

Non-invasive ventilation in motor neuron disease: an update of current UK practice.

O'Neill CL, Williams TL, Peel ET, McDermott CJ, Shaw PJ, Gibson GJ, Bourke SC.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):371-6. doi: 10.1136/jnnp-2011-300480. Epub 2011 Aug 17.

PMID:
21849339
24.

Rebound hypoxaemia after administration of oxygen in an acute exacerbation of chronic obstructive pulmonary disease.

Kane B, Turkington PM, Howard LS, Davison AG, Gibson GJ, O'Driscoll BR.

BMJ. 2011 Mar 31;342:d1557. doi: 10.1136/bmj.d1557. No abstract available.

PMID:
21454455
25.

Modeling the consistency of hypoglycemic symptoms: high variability in diabetes.

Zammitt NN, Streftaris G, Gibson GJ, Deary IJ, Frier BM.

Diabetes Technol Ther. 2011 May;13(5):571-8. doi: 10.1089/dia.2010.0207. Epub 2011 Mar 17.

PMID:
21413888
26.

Nanometric depth resolution from multi-focal images in microscopy.

Dalgarno HI, Dalgarno PA, Dada AC, Towers CE, Gibson GJ, Parton RM, Davis I, Warburton RJ, Greenaway AH.

J R Soc Interface. 2011 Jul 6;8(60):942-51. doi: 10.1098/rsif.2010.0508. Epub 2011 Jan 19.

27.

Predicting outcomes following hospitalization for acute exacerbations of COPD.

Steer J, Gibson GJ, Bourke SC.

QJM. 2010 Nov;103(11):817-29. doi: 10.1093/qjmed/hcq126. Epub 2010 Jul 26. Review.

PMID:
20660633
28.

Randomised cross-over study of oral appliances for snoring.

Maguire J, Steele JG, Gibson GJ, Wilson JA, Steen N, McCracken GI.

Clin Otolaryngol. 2010 Jun;35(3):204-9. doi: 10.1111/j.1749-4486.2010.02126.x.

PMID:
20636739
29.

Night-to-night variation in snoring sound severity: one night studies are not reliable.

Cathcart RA, Hamilton DW, Drinnan MJ, Gibson GJ, Wilson JA.

Clin Otolaryngol. 2010 Jun;35(3):198-203. doi: 10.1111/j.1749-4486.2010.02127.x.

PMID:
20636738
30.

Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function.

Tennant PW, Gibson GJ, Parker L, Pearce MS.

Chest. 2010 Jan;137(1):146-55. doi: 10.1378/chest.09-0352. Epub 2009 Jul 6.

PMID:
19581355
31.

Cancellous bone properties and matrix content of TGF-beta2 and IGF-I in human tibia: a pilot study.

Yeni YN, Dong XN, Zhang B, Gibson GJ, Fyhrie DP.

Clin Orthop Relat Res. 2009 Dec;467(12):3079-86. doi: 10.1007/s11999-009-0896-5. Epub 2009 May 27.

32.

Spatio-temporal stochastic modelling of Clostridium difficile.

Starr JM, Campbell A, Renshaw E, Poxton IR, Gibson GJ.

J Hosp Infect. 2009 Jan;71(1):49-56. doi: 10.1016/j.jhin.2008.09.013. Epub 2008 Nov 17.

PMID:
19013677
33.

Examination of the effect of aphid vector population composition on the spatial dynamics of citrus tristeza virus spread by stochastic modeling.

Gottwald TR, Gibson GJ, Garnsey SM, Irey M.

Phytopathology. 1999 Jul;89(7):603-8. doi: 10.1094/PHYTO.1999.89.7.603.

34.

Multilayered 3D Lidar image construction using spatial models in a Bayesian framework.

Hernandez-Marin S, Wallace AM, Gibson GJ.

IEEE Trans Pattern Anal Mach Intell. 2008 Jun;30(6):1028-40. doi: 10.1109/TPAMI.2008.47.

PMID:
18421108
35.

Lifecourse predictors of adult respiratory function: results from the Newcastle Thousand Families Study.

Tennant PW, Gibson GJ, Pearce MS.

Thorax. 2008 Sep;63(9):823-30. doi: 10.1136/thx.2008.096388. Epub 2008 Apr 11.

PMID:
18408051
36.

Constructing the effect of alternative intervention strategies on historic epidemics.

Cook AR, Gibson GJ, Gottwald TR, Gilligan CA.

J R Soc Interface. 2008 Oct 6;5(27):1203-13. doi: 10.1098/rsif.2008.0030.

37.

Two algorithms for neural-network design and training with application to channel equalization.

Sweatman CZ, Mulgrew B, Gibson GJ.

IEEE Trans Neural Netw. 1998;9(3):533-43. doi: 10.1109/72.668895.

PMID:
18252477
38.

Estimation of multiple transmission rates for epidemics in heterogeneous populations.

Cook AR, Otten W, Marion G, Gibson GJ, Gilligan CA.

Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20392-7. Epub 2007 Dec 11.

39.

Optimal observation times in experimental epidemic processes.

Cook AR, Gibson GJ, Gilligan CA.

Biometrics. 2008 Sep;64(3):860-8. Epub 2007 Nov 12.

PMID:
18047537
40.

Bayesian analysis of Lidar signals with multiple returns.

Hernández-Marín S, Wallace AM, Gibson GJ.

IEEE Trans Pattern Anal Mach Intell. 2007 Dec;29(12):2170-80.

PMID:
17934226
41.

Surface-enhanced Raman scattering-based nanoprobe for high-resolution, non-scanning chemical imaging.

Hankus ME, Li H, Gibson GJ, Cullum BM.

Anal Chem. 2006 Nov 1;78(21):7535-46.

PMID:
17073424
42.
43.

Comparison of manual sleep staging with automated neural network-based analysis in clinical practice.

Caffarel J, Gibson GJ, Harrison JP, Griffiths CJ, Drinnan MJ.

Med Biol Eng Comput. 2006 Mar;44(1-2):105-10.

PMID:
16929927
44.

Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data.

Forrester ML, Pettitt AN, Gibson GJ.

Biostatistics. 2007 Apr;8(2):383-401. Epub 2006 Aug 22.

PMID:
16926230
45.
46.

Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.

Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D.

Hepatology. 2006 Jul;44(1):91-8.

PMID:
16800007
47.

Improvement of respiratory failure with NIV.

Gibson GJ.

Thorax. 2006 Jun;61(6):545; author reply 545. No abstract available.

48.

Re: Spirometry vs. peak flow in COPD.

Gibson GJ.

Prim Care Respir J. 2004 Dec;13(4):225; author reply 227-8. No abstract available.

49.

Silencing the snorers: no gain without pain?

Wilson JA, Lester SE, Gibson GJ, Anari S, Steele JG, Steen IN, McCracken GI.

J Laryngol Otol. 2006 Jul;120(7):570-4. Epub 2006 May 12.

PMID:
16690008
50.

Evaluation of potential predictors of outcome of laser-assisted uvulopalatoplasty for snoring.

Macdonald A, Drinnan M, Johnston A, Reda M, Griffiths C, Wilson J, Gibson GJ.

Otolaryngol Head Neck Surg. 2006 Feb;134(2):197-203.

PMID:
16455364

Supplemental Content

Loading ...
Support Center